Metabolism

Shop By

Items 351-400 of 756

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. PDI inhibitor

    CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.
  2. PDE5 inhibitor

    Sildenafil Mesylate is a mesylate form of Sildenafil, an inhibitor of Phosphodiesterase 5.
  3. alcohol dehydrogenase inhibitor

    Fomepizole is an alcohol dehydrogenase inhibitor used for the treatment of ethylene glycol and methanol poisonings in adults.
  4. PHGDH inhibitor

    CBR 5884 is an inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH), inhibiting serine synthesis from 3-phosphoglycerate in cells with an IC50 value of 33 uM.
  5. CYP2C9 inhibitor

    Benzbromarone is a CYP2C9 inhibitor, it binds to CYP2C9 with Ki value of 19.3 nM.
  6. pan-WNK-kinase inhibitor

    WNK463 is an orally bioavailable pan-WNK-kinase inhibitor.
  7. ribonucleotide reductase inhibitor

    Didox is a strong inhibitor of ribonucleotide reductase (RR) that interferes with DNA synthesis and repair by blocking the production of deoxyribonucleotides and has demonstrated antitumor effects for decades.
  8. LYPLA1 inhibitor

    ML348 is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50 = 210 nM), Exhibits 14-fold selectivity for LYPLA1 over LYPLA2, Also selective over a panel of ~30 other serine hydrolases.
  9. SINE/CRM1 inhibitor

    KPT276, analog of KPT-185, is a selective inhibitor of nuclear export (SINE) and CRM1.
  10. HSF inhibitor

    KRIBB11 is an inhibitor of Heat shock factor (HSF) inhibitor, with IC50 of 1.2 μM.
  11. MGL inhibitor

    URB602 is a selective inhibitor of monoglycerol lipase (MGL), exhibiting an IC50 of 28 μM for the rat brain enzyme.
  12. Tryptophan hydroxylase inhibitor

    4-Chloro-DL-phenylalanine is a selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE).
  13. glucose metabolism inhibitor

    2-Deoxy-D-glucose is a glucose analog that acts as a competitive inhibitor of glucose metabolism, inhibiting glycolysis via its actions on hexokinase.
  14. α-glucosidase inhibitor

    Hexylresorcinol (4-Hexylresorcinol) is a natural compound found in plants with antimicrobial, anthelmintic, antiseptic and antitumor activities. Hexylresorcinol can induce apoptosis in squamous carcinoma cells. Hexylresorcinol is a reversible and noncompetitive inhibitor of α-glucosidase. Hexylresorcinol has protective effects against oxidative DNA damage.
  15. ferroptosis inhibitor

    Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM).
  16. COX-2 inhibitor

    Salicylic acid (2-Hydroxybenzoic acid) is a beta hydroxy acid that occurs as a natural compound in plants which is an inhibitor of ethylene biosynthesis and cyclooxygenase activity.
  17. diacylglycerol lipase (DAGL) inhibitor

    DO34 is a novel potent and selective diacylglycerol lipase (DAGL) inhibitor.
  18. ACE2 inhibitor

    MLN-4760 is an angiotensin-converting (ACE2) inhibitor. In huMNCs, MLN-4760-B detected 63% ACE2 with 28-fold selectivity over ACE.
  19. sEH inhibitor

    UC-1728, also known as t-TUCB, is a soluble epoxide hydrolase inhibitor.
  20. CYP1A1 inhibitor

    Bergamottin is a furanocoumarin found in grapefruit juice and lemon, lime, and bergamot oils that has diverse biological activities.
  21. IDH1 Inhibitor

    Vorasidenib, also known as AG-881, is a potent and selective orally available inhibitor of mutated forms of both isocitrate dehydrogenase type 1 (IDH1, IDH1 [NADP+] soluble) in the cytoplasm and type 2 (IDH2, isocitrate dehydrogenase [NADP+], mitochondrial) in the mitochondria, with potential antineoplastic activity.
  22. LOXL2 inhibitor

    LOXL2-IN-1 HCl is a selective LOXL2 inhibitor with an IC50 of 126 nM.
  23. PGC-1α inhibitor

    SR 18292 is a PGC-1α inhibitor. It reduces blood glucose, strongly increases hepatic insulin sensitivity, and improves glucose homeostasis in dietary and genetic mouse models of T2D.
  24. SCD1 inhibitor

    CAY10566 is a potent and selective inhibitor of SCD1 that demonstrates IC50 values of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.
  25. IDH1 inhibitor

    IDH305 is an inhibitor of the citric acid cycle enzyme isocitrate dehydrogenase [NADP] cytoplasmic (isocitrate dehydrogenase 1; IDH1) with mutations at residue R132 (IDH1(R132)), with potential antineoplastic activity.
  26. CYP51 inhibitor

    Tebuconazole is a triazole fungicide used agriculturally to treat plant pathogenic fungi.
  27. PDE4 inhibitor

    Roflumilast N-oxide is the active metabolite of roflumilast. Roflumilast N-oxide is a phosphodiesterase 4 inhibitor.
  28. DHFR inhibitor

    Diaveridine (EGIS-5645) is a dihydrofolate reductase (DHFR) inhibitor with a Ki of 11.5 nM for the wild type DHFR and also an antibacterial agent.
  29. PDE7 inhibitor

    BRL-50481 acts as a phosphodiesterase inhibitor selective for the PDE7 subtype.
  30. IDO1 inhibitor

    BMS-986205, also known as Linrodostat, ONO-7701 and F001287, a potent and selective, orally active IDO1 inhibitor with potential immunomodulating and antineoplastic activities. CAS: 1923833-60-6 (free base) 2221034-29-1 (mesylate)
  31. PDE9 inhibitor

    BAY 73-6691 is a potent, selective brain penetrant PDE9A inhibitor.
  32. mIDH1 inhibitor

    BAY-1436032 is a potent, selective and orally available inhibitor of mutant Isocitrate Dehydrogenase 1 (mIDH1).
  33. human cytochrome P450IA2 inhibitor

    Furafylline is a potent and selective inhibitor of human cytochrome P450IA2 with an IC50 of 0.07 μM.
  34. PDE4 inhibitor

    BW-A78U is a PDE4 inhibitor with an IC50 of 3 μM.
  35. COX and lipo-oxygenase inhibitor

    Timegadine, a new antiinflammatory agent, is found to be a potent, competitive inhibitor of cyclo-oxygenase (COX) and lipo-oxygenase, with IC50s ranging from 5 nM (washed rabbit platelets) to 20 μM (rat brain) for COX and 100 μM for lipo-oxygenase both in the cytosol fraction of horse platelet homogenates, and in washed rabbit platelets.
  36. GAK inhibitor

    SGC GAK 1 is a high affinity cyclin G associated kinase (GAK) inhibitor.
  37. PHGDH inhibitor

    NCT-503 is an inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH) with an IC50 value of 2.5 μM.
  38. TLR/SCD inhibitor

    E6446 dihydrochloride is a robust antagonist for TLR7 and TLR9, with potential applications in studying harmful inflammatory responses. Additionally, it acts as a significant inhibitor of SCD1 with a KD of 4.61 μM. This compound can notably suppress adipogenic differentiation and liver lipogenesis via the SCD1-ATF3 pathway. Studies have indicated that E6446 dihydrochloride can enhance liver pathology in mice on a high-fat diet, making it a potential candidate for researching non-alcoholic fatty liver disease (NAFLD).

  39. uPA inhibitor

    UK-371804 is a potent urokinase-type plasminogen activator (uPA) inhibitor.
  40. FAAH inhibitor

    BIA10-2474 is a long-acting reversible inhibitor of fatty acid amide hydrolase (FAAH) .
  41. RNR Inhibitor

    COH29 is a potent ribonucleotide reductase (RNR) inhibitor with anticancer activity.
  42. exportin-1 inhibitor

    Eltanexor, also known as KPT-8602, is a second-generation exportin-1 inhibitor.
  43. PFKFB3 inhibitor

    AZ-PFKFB3-67 is a novel potent and selective PFKFB3 inhibitor.
  44. GLUT1 Inhibitor

    BAY-876 is a potent and Selective GLUT1 Inhibitor. BAY-876 showed good metabolic stability in vitro and high oral bioavailability in vivo.
  45. PUN30119, also known as Imidazole ketone erastin (IKE), is a potent, metabolically stable inhibitor of system xc- and inducer of ferroptosis potentially suitable for in vivo applications.
  46. Fer and FerT inhibitor

    E260 is a novel inhibitor of the Fer/FerT kinase with Kd of 0.85 uM.
  47. alpha-adrenergic receptor agonist / MAO inhibitor

    Amitraz, also known as Mitaban and Taktic, is an alpha-adrenergic receptor agonist and MAO inhibitor used as an insecticide in prevention of flea and tick infections. It prevents prostaglandin synthesis and may inhibit beta-cell insulin release.
  48. ER stress inhibitor

    Tauroursodeoxycholate (TUDCA; UR 906; Taurolite) is an endoplasmic reticulum (ER) stress inhibitor.
  49. CYP2C9 inhibitor

    Sulfaphenazole is a specific inhibitor of CYP2C9 which blocks atherogenic and pro-inflammatory effects of linoleic acid (increase in oxidative stress and activation of AP-1) mediated by CYP2C9.
  50. MAO inhibitor

    Pargyline hydrochloride is an irreversible inhibitor of monoamine oxidase (MAO) that is used clinically to treat moderate hypertension.

Items 351-400 of 756

Page
per page
Set Descending Direction